Glenmark Pharmaceuticals Limited announced new developments that should accelerate the launch of Crofelemer, a novel drug in development for multiple indications including HIV-associated diarrhoea by a consortium of partners including Glenmark.
The details can be read here.
No comments:
Post a Comment